|

About Us

Home - - About Us



  •     Mab-Venture was established in early 2014 in Shanghai’s Zhangjiang Hi-Tech Park. It is a fully integrated biologics CRO/CDMO dedicated to the whole industry chain from research to commercialization. Mab-Venture is also committed to developing a biopharmaceutical research and development platform. In May 2015, Mab-Venture built a new 1700 sq.m. R&D and pilot production base in Shanghai’s Zhangjiang International Medical Park. In March 2017, Mab-Venture built an additional 3350 sq.m. pilot production base. The two facilities provide an end-to-end solution from research to four pilot production lines to support biologics development and manufacture in the pre-clinical and early clinical stages. R & D equipment investment thus far has been >$20 million dollars. The Mab-Venture team is just over 145 people and is expanding rapidly, with headcount expected to be over 200 by the end of 2018.

        In April 2017, Mab-Venture and Thermo Fisher Scientific signed a strategic cooperation and will jointly establish Asia-Pacific’s first antibody drug "SmartFactory", to accelerate the development of biopharmaceuticals. The center will provide a variety of antibody contract development (CRO) and contract manufacturing (CMO) services.

    The company's Sr. Management team has over 20 years of biologics R&D experience in various areas including; analytical and bioanalytical R&D, process development, cGMP manufacturing, pre-clinical in vivo studies, antibody discovery, and target validation. Mab-Venture’s Senior Management gained its experience working in academia and multinational biopharma such as Amgen, Novartis, J&J, Roche, and other leading global biopharmaceutical companies

     

        We provide standalone technical services for various stages of development and also end to end support for biologics R&D from discovery to clinical studies. We are focused on the establishment of a high quality integrated services platform to support global development.

    Our capabilities include but are not limited to:

     ● Analytical quality method development, validation, and lot release of antibody therapeutics. Product Characterization, GMP stability

     ● Cell line development, process development (upstream/downstream), pilot scale production for IND filings / early clinical manufacture

     ● Development and validation of bioanalytical methods

     ● Immunogenicity study and program design

     ● Pharmacodynamic and pharmacokinetic study design and execution

     ● IND filing support and consultation services

    As of 2018, Mab-Venture hasover 40 clients/partners across the globe. 




    Follow us
      WeChat
      
    Contact Us
       info@mab-venture.com
       +86 21 5018 6802
        Ste.2-301,1199 Landian Road,Pudong District,Shanghai 201318,China

             Copyright © 2014 - 2017 上海博威生物医药有限公司 版权所有